Pharmaceutical - Production, Bristol-Myers Squibb


Popular Filters

Bristol-Myers partners with South Korean firm on biopharma production


US pharma major Bristol-Myers Squibb (NYSE: BMY) has entered into a 10-year agreement under which Samsung…

Asia-PacificBiotechnologyBristol-Myers SquibbOncologyPharmaceuticalProductionSamsung BioLogics

Bristol-Myers pumps about $250 million into biologics facility expansion


Just a few days after announcing the closure of its biotech subsidiary Amylin facility in California…

BiotechnologyBristol-Myers SquibbFinancialPharmaceuticalProductionResearch

Back to top